Prognostic impact of the BAGS2Clinic assay in an independent validation cohort. OS (A) and PFS (B) evaluated by Kaplan-Meier survival curves indicating the prognostic impact of BAGS2Clinic on the validation cohort (n = 77). HRs were computed by Cox regression. All unclassified samples were excluded from the survival analysis. CB, centroblast; CC, centrocyte; M, memory; PB, plasmablast.